PLATELET-FACTOR-3 IN PLASMA FRACTIONS - ITS RELATION TO MICROPARTICLE SIZE AND THROMBOSES

被引:52
作者
JY, WC
HORSTMAN, LL
WANG, F
DUNCAN, RC
AHN, YS
机构
[1] The William J. Harrington Sr. Center for Blood Diseases Dept. of Medicine, University of Miami, Miami, FL
关键词
COAGULATION; PLATELET FACTOR 3; PLATELET MICROPARTICLES; RUSSELLS VIPER VENOM;
D O I
10.1016/0049-3848(95)00202-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Platelet factor 3 (PF3) was assayed by Russell's viper venom (RVV) in three plasma fractions, platelet-rich plasma (PRP), platelet poor plasma (PPP), and 0.1 mu m particle-filtered plasma (PFP), in 42 healthy controls, 34 patients with recent cerebrovascular accidents (CVA) and 28 with recent ischemic events from coronary artery disease (CAD). Platelet microparticles (PMP) were assayed in PPP by flow cytometry. Relative to controls, the RVV clotting times were shortened in all three plasma fractions in both patient groups, p < 0.001. PMP were also elevated in both patient groups, p < 0.001. Linear regression analysis showed that the RVV times of PPP are inversely correlated with PMP, p < 0.005, in patient groups but not in controls. There was no correlation of RVV time with PT, APTT or FIB. After converting RVV times to units of PF3 activity, it could be shown that only about 1/4 of the total PF3 activity was contributed by platelets. The major contribution to the PF3 activity in controls was from microparticles < 0.1 mu m but in patients was due mainly to microparticles > 0.1 mu m The RVV time was superior to routine coagulation tests in discriminating thrombotic patients from healthy controls.
引用
收藏
页码:471 / 482
页数:12
相关论文
共 32 条
[1]   CHANGES IN MEMBRANE PHOSPHOLIPID DISTRIBUTION DURING PLATELET ACTIVATION [J].
BEVERS, EM ;
COMFURIUS, P ;
ZWAAL, RFA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 736 (01) :57-66
[2]   ASSOCIATION OF FACTOR-V ACTIVITY WITH MEMBRANOUS VESICLES RELEASED FROM HUMAN-PLATELETS - REQUIREMENT FOR PLATELET STIMULATION [J].
BODE, AP ;
SANDBERG, H ;
DOMBROSE, FA ;
LENTZ, BR .
THROMBOSIS RESEARCH, 1985, 39 (01) :49-61
[3]   ANALYSIS OF PLATELET FACTOR-III IN PLATELET CONCENTRATES STORED FOR TRANSFUSION [J].
BODE, AP ;
MILLER, DT .
VOX SANGUINIS, 1986, 51 (04) :299-305
[4]  
DACHARYPRIGENT J, 1993, BLOOD, V81, P2554
[5]   Molecular markers of hemostatic activation: Applications in the diagnosis of thrombosis and vascular and thrombotic disorders [J].
Fareed, J ;
Bick, RL ;
Hoppensteadt, DA ;
Bermes, EW .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 1995, 1 (02) :87-102
[6]   PLATELET SURFACE GLYCOPROTEINS - STUDIES ON RESTING AND ACTIVATED PLATELETS AND PLATELET MEMBRANE MICROPARTICLES IN NORMAL SUBJECTS, AND OBSERVATIONS IN PATIENTS DURING ADULT RESPIRATORY-DISTRESS SYNDROME AND CARDIAC-SURGERY [J].
GEORGE, JN ;
PICKETT, EB ;
SAUCERMAN, S ;
MCEVER, RP ;
KUNICKI, TJ ;
KIEFFER, N ;
NEWMAN, PJ .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (02) :340-348
[7]   PLATELET AGGREGATION AND AVAILABILITY OF PLATELET FACTOR 3 [J].
HARDISTY, RM ;
HUTTON, RA .
BRITISH JOURNAL OF HAEMATOLOGY, 1966, 12 (06) :764-&
[8]  
HARDISTY RM, 1966, BRIT J HAEMATOL, V11, P258
[9]  
HORSTMAN LL, 1994, J LAB CLIN MED, V123, P515
[10]  
HORSTMAN LL, 1995, IN PRESS THROMB RES